Fund moves

Johnson & Johnson (JNJ): Dakota Wealth Management reduced its stake -1,709 shares

Dakota Wealth Management reduced its stake in Johnson & Johnson, per its Q2 2025 13F.

112K
Shares reported · -1,709 vs prior quarter
0.36%
Disclosed portfolio weight
$17.1M
Reported value
Holdings as of
Jun 30, 2025
Filed
Jul 16, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 15, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. Aug 7, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  3. Sep 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Oct 29, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Mar 19, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
  6. May 12, 2025CongressDisclosed sale of JNJ — reported range $50,001 - $100,000
  7. May 30, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  8. Jun 10, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  9. Jun 12, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
  10. Jun 16, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
  11. Jun 17, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  12. Jun 24, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000

What came next

  1. Jul 17, 2025InsiderOfficer sold ~$3.13M of JNJ shares in the open market
  2. Jul 31, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  3. Aug 4, 2025Congress · 1 personMembers of Congress: 2 purchases
  4. Aug 14, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  5. Aug 15, 2025InsiderCFO sold ~$2.98M of JNJ shares in the open market
  6. Aug 19, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  7. Aug 22, 2025InsiderCEO sold ~$22.5M of JNJ shares in the open market
  8. Sep 4, 2025Insider · 4 days before an 8-KOfficer sold ~$10M of JNJ shares in the open market
  9. Sep 8, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 8, 2025, Johnson & Johnson (the Company) announced that John Morikis was elected to the Board of Directors. The Board has determined that Mr. Morikis satisfies the applicable independence requirements of the NYSE Listed Company Manual.”
  10. Sep 9, 2025FDAFDA drug approval: Inlexzo
  11. Sep 11, 2025FDARecall: ECHELON LINEAR Cutters Reload 80 mm Blue, intended for transection, resection, and/or creation of anastomoses, Product Number GLC80
  12. Sep 16, 2025FDARecall: Automated Impella Controller (AIC) labeled as the following with corresponding Product Codes: 1. AIC w/Impella Connect for ECP, Product Code: 1000432. 2. Dbl o…
  13. Sep 19, 2025FDAFDA drug approval: Tremfya
  14. Sep 23, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  15. Sep 26, 2025FDAFDA drug approval: Tremfya
  16. Sep 26, 2025FDAFDA drug approval: Tremfya
  17. Sep 26, 2025FDARecall: LOW PROF LCKNG SCREW, F/IM NAIL 5.0MM / L, 42MM / XL25/ STER. Product Code: 04.045.342TS. Used in RFN-ADVANCEDTM Retrograde Femoral Nailing (RFNA) System and t…
  18. Sep 26, 2025FDARecall: LOW PROF LCKNG SCREW, F/IM NAIL 5.0MM / L, 46MM / XL25/ STER. Product Code: 04.045.346TS. Used in RFN-ADVANCEDTM Retrograde Femoral Nailing (RFNA) System and t…
  19. Oct 1, 2025FDARecall: Automated Impella Controller (AIC), used for left heart support blood pump, labeled as the following with corresponding Product Codes: 1. Impella Controller, P…
  20. Oct 8, 2025FDAFDA device clearance: 14Fr Low Profile Introducer Kit
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 4 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

How this filing works

Explore the data

Common questions

What does this filing report about Johnson & Johnson (JNJ) stock?

Dakota Wealth Management reduced its stake in Johnson & Johnson, per its Q2 2025 13F. Now 112K shares, $17.1M reported value, 0.36% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2025. Filed: Jul 16, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Johnson & Johnson recently?

For Johnson & Johnson, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 4 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days. They are listed on the JNJ page.

Does this mean JNJ stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data